DALLAS, Jan. 14, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring drug company NexMed Inc. (Nasdaq:NEXM). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
It is available at: http://www.beaconequity.com/i/NEXM
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
NexMed Inc. (NEXM) is a pharmaceutical and medical technology company with a focus on developing and commercializing therapeutic products based on its delivery systems. The Company focuses its efforts on new and topical pharmaceutical products based on a penetration enhancement drug delivery technology known as NexACT, which may enable an active drug to be better absorbed through the skin. The NexACT transdermal drug delivery technology is designed to enhance the absorption of an active drug through the skin, overcoming the skin's natural barrier properties, and enabling high concentrations of the active drug to rapidly penetrate the desired site of the skin or extremity.
Message Board Search for NEXM: http://www.boardcentral.com/boards/NEXM
In the report, the analyst notes:
"NEXM has experienced net losses and negative cash flows from operations each year since its inception. Through September 30, 2009, it had an accumulated deficit of $141,621,302. Its operations have principally been financed through private placements of equity securities and debt financing. Funds raised in past periods should not be considered an indication of the Company's ability to raise additional funds in any future periods.
"NEXM in late December announced the closing of its acquisition of Bio-Quant Inc., a privately held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, Calif. Upon closing, Bio-Quant became a wholly owned subsidiary of NEXM."
To read the entire report visit: http://www.beaconequity.com/i/NEXM
See what investors are saying about NEXM at penny stock forum
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
CONTACT: Beacon Equity Research
Jeff Bishop
(469)-252-3505
press@beaconequity.com
